Maat Pharma SA
PAR:MAAT
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| FR |
M
|
Maat Pharma SA
PAR:MAAT
|
134.6m EUR |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
394.1B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.3B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
188.3B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.5B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.8B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
89B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.6B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -147 400% |
| 30th Percentile | -2.2% |
| Median | 2.6% |
| 70th Percentile | 7.1% |
| Max | 14 243.8% |
Other Profitability Ratios
Maat Pharma SA
Glance View
Maat Pharma SA operates as a clinical-stage microbiome therapeutics company. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 43 full-time employees. The company went IPO on 2021-11-08. The firm specializes in the microbiome therapy that is aimed to treatment of Gut Microbiota alteration (Dysbiosis) using patient-specific biotherapeutics in patients with serious medical conditions. Its MaaT Microbiome Restoration Therapy (MMRB) discovery and analysis platform supports the evaluation of drug candidates, the determination of new disease targets and the identification of biomarkers for microbiome-related conditions.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Maat Pharma SA is -792.6%, which is above its 3-year median of -831.5%.
Over the last 3 years, Maat Pharma SA’s Net Margin has increased from -1 146.1% to -792.6%. During this period, it reached a low of -1 146.1% on Jun 30, 2022 and a high of -636.6% on Jun 30, 2023.
